BlackRock’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.8M | Buy |
692,650
+47,043
| +7% | +$2.68M | ﹤0.01% | 2501 |
|
|
2025
Q4 | $27.3M | Buy |
645,607
+36,493
| +6% | +$2.04M | ﹤0.01% | 2912 |
|
|
2025
Q3 | $34.7M | Buy |
609,114
+193,888
| +47% | +$6.42M | ﹤0.01% | 2739 |
|
|
2025
Q2 | $10.7M | Sell |
415,226
-631,929
| -60% | -$7.1M | ﹤0.01% | 3378 |
|
|
2025
Q1 | $10.7M | Sell |
1,047,155
-25,617
| -2% | -$335K | ﹤0.01% | 3281 |
|
|
2024
Q4 | $15M | Buy |
1,072,772
+8,149
| +0.8% | +$144K | ﹤0.01% | 3213 |
|
|
2024
Q3 | $20.8M | Buy |
1,064,623
+54,245
| +5% | +$1.03M | ﹤0.01% | 3017 |
|
|
2024
Q2 | $18.8M | Buy |
1,010,378
+618,492
| +158% | +$13M | ﹤0.01% | 3026 |
|
|
2024
Q1 | $5.49M | Sell |
391,886
-15,062
| -4% | -$158K | ﹤0.01% | 3631 |
|
|
2023
Q4 | $3.45M | Sell |
406,948
-105,361
| -21% | -$798K | ﹤0.01% | 3843 |
|
|
2023
Q3 | $4.58M | Sell |
512,309
-61,312
| -11% | -$590K | ﹤0.01% | 3690 |
|
|
2023
Q2 | $4.95M | Sell |
573,621
-1,796,976
| -76% | -$19.2M | ﹤0.01% | 3734 |
|
|
2023
Q1 | $25M | Sell |
2,370,597
-24,784
| -1% | -$750K | ﹤0.01% | 2857 |
|
|
2022
Q4 | $81.2M | Buy |
2,395,381
+58,680
| +3% | +$2.84M | ﹤0.01% | 2144 |
|
|
2022
Q3 | $112M | Buy |
2,336,701
+231,840
| +11% | +$13.8M | ﹤0.01% | 1890 |
|
|
2022
Q2 | $120M | Buy |
2,104,861
+363,893
| +21% | +$23M | ﹤0.01% | 1904 |
|
|
2022
Q1 | $141M | Sell |
1,740,968
-37,152
| -2% | -$5.5M | ﹤0.01% | 1908 |
|
|
2021
Q4 | $360M | Buy |
1,778,120
+521,837
| +42% | +$113M | 0.01% | 1279 |
|
|
2021
Q3 | $338M | Buy |
1,256,283
+16,532
| +1% | +$3.98M | 0.01% | 1307 |
|
|
2021
Q2 | $319M | Sell |
1,239,751
-28,725
| -2% | -$7.95M | 0.01% | 1424 |
|
|
2021
Q1 | $381M | Buy |
1,268,476
+43,271
| +4% | +$13.5M | 0.01% | 1251 |
|
|
2020
Q4 | $312M | Buy |
1,225,205
+26,793
| +2% | +$6.92M | 0.01% | 1267 |
|
|
2020
Q3 | $298M | Sell |
1,198,412
-47,130
| -4% | -$14.8M | 0.01% | 1080 |
|
|
2020
Q2 | $433M | Buy |
1,245,542
+40,933
| +3% | +$12.8M | 0.02% | 811 |
|
|
2020
Q1 | $323M | Sell |
1,204,609
-23,227
| -2% | -$7.18M | 0.02% | 853 |
|
|
2019
Q4 | $398M | Buy |
1,227,836
+323,951
| +36% | +$93.9M | 0.02% | 972 |
|
|
2019
Q3 | $247M | Buy |
903,885
+19,553
| +2% | +$7.17M | 0.01% | 1250 |
|
|
2019
Q2 | $472M | Buy |
884,332
+49,976
| +6% | +$25.1M | 0.02% | 780 |
|
|
2019
Q1 | $421M | Sell |
834,356
-30,923
| -4% | -$18.3M | 0.02% | 850 |
|
|
2018
Q4 | $427M | Sell |
865,279
-9,505
| -1% | -$5.74M | 0.02% | 743 |
|
|
2018
Q3 | $800M | Buy |
874,784
+30,877
| +4% | +$26.4M | 0.03% | 505 |
|
|
2018
Q2 | $618M | Sell |
843,907
-120,827
| -13% | -$139M | 0.03% | 602 |
|
|
2018
Q1 | $1.54B | Sell |
964,734
-464,025
| -32% | -$598M | 0.07% | 269 |
|
|
2017
Q4 | $1.28B | Buy |
1,428,759
+28,751
| +2% | +$17M | 0.06% | 316 |
|
|
2017
Q3 | $504M | Buy |
1,400,008
+51,909
| +4% | +$16.2M | 0.03% | 662 |
|
|
2017
Q2 | $395M | Buy |
1,348,099
+12,396
| +0.9% | +$3.58M | 0.02% | 783 |
|
|
2017
Q1 | $470M | Buy |
1,335,703
+1,334,963
| +180,400% | +$300M | 0.03% | 683 |
|
|
2016
Q4 | $136K | Sell |
740
-119
| -14% | -$24.2K | ﹤0.01% | 2373 |
|
|
2016
Q3 | $221K | Buy |
859
+80
| +10% | +$20.6K | ﹤0.01% | 2094 |
|
|
2016
Q2 | $166K | Buy |
779
+178
| +30% | +$39.8K | ﹤0.01% | 2211 |
|
|
2016
Q1 | $124K | Buy |
601
+257
| +75% | +$49.4K | ﹤0.01% | 1904 |
|
|
2015
Q4 | $87K | Buy |
344
+145
| +73% | +$29.8K | ﹤0.01% | 1817 |
|
|
2015
Q3 | $33K | Sell |
199
-31
| -13% | -$5.48K | ﹤0.01% | 2110 |
|
|
2015
Q2 | $43K | Sell |
230
-15
| -6% | -$2.58K | ﹤0.01% | 2036 |
|
|
2015
Q1 | $40K | Hold |
245
| – | – | ﹤0.01% | 2044 |
|
|
2014
Q4 | $57K | Hold |
245
| – | – | ﹤0.01% | 1891 |
|
|
2014
Q3 | $45K | Hold |
245
| – | – | ﹤0.01% | 1955 |
|
|
2014
Q2 | $47K | Sell |
245
-7
| -3% | -$1.24K | ﹤0.01% | 1952 |
|
|
2014
Q1 | $46K | Buy |
252
+11
| +5% | +$2.18K | ﹤0.01% | 1953 |
|
|
2013
Q4 | $41K | Sell |
241
-8
| -3% | -$1.29K | ﹤0.01% | 2004 |
|
|
2013
Q3 | $39K | Buy |
249
+9
| +4% | +$1.66K | ﹤0.01% | 1943 |
|
|
2013
Q2 | $41K | Buy |
+240
| New | +$36.8K | ﹤0.01% | 1939 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
BlackRock's NKTR Position: Q1 2026 in Review
BlackRock increased its Nektar Therapeutics (NKTR) stake by 7.3% in Q1 2026, buying an estimated $2.68M and bringing the position to 692,650 shares worth $49.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2501.
BlackRock first reported a position in NKTR in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- BlackRock held 692,650 shares of Nektar Therapeutics worth $49.8M as of Q1 2026.
- BlackRock bought 47,043 Nektar Therapeutics shares in Q1 2026, an estimated $2.68M.
- Nektar Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2501 holding.
- BlackRock first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 52 quarters since.
- BlackRock's Nektar Therapeutics position peaked at $1.54B in Q1 2018.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.